Novartis Investigative Site

Clinton Township, Michigan 48038

0 studies enrolling now · 3 studies all time

What they study most

Advancing Multiple Sclerosis, Multiple Sclerosis, Plaque-type Psoriasis, Relapsing Multiple Sclerosis

Studies at this site

• Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients — Completed
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis — Completed
• AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis — Completed